Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ
Open Access
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 97 (6) , 1356-1365
- https://doi.org/10.1016/s0091-6749(96)70205-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavityJournal of Allergy and Clinical Immunology, 1991
- Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: Changes in inflammatory mediators and cellsJournal of Allergy and Clinical Immunology, 1991
- Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.BMJ, 1991
- Changes in nasal metachromatic cells during allergen immunotherapyClinical and Experimental Allergy, 1991
- Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoidsJournal of Allergy and Clinical Immunology, 1990
- CSM Update: Desensitising vaccinesBMJ, 1986
- Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.Journal of Clinical Investigation, 1985
- The Subclass Nature and Clinical Significance of the IgG Antibody Response in Patients Undergoing Allergen‐Specific ImmunotherapyAllergy, 1985
- IgE Antibody Measurements in Ragweed Hay Fever RELATIONSHIP TO CLINICAL SEVERITY AND THE RESULTS OF IMMUNOTHERAPYJournal of Clinical Investigation, 1973
- PROPHYLAXIS OF SUMMER HAY-FEVER AND ASTHMA: A CONTROLLED TRIAL COMPARING CRUDE GRASS-POLLEN EXTRACTS WITH THE ISOLATED MAIN PROTEIN COMPONENTPublished by Elsevier ,1954